NovaBridge Biosciences NBP
NASDAQ NBP
$1.37 -0.05 (-3.86%)
At close: Oct 21, 2026 · 4:00 PM EDT

NovaBridge Biosciences (NBP) Net Margin (2019 - 2023)

Updated

NovaBridge Biosciences (NBP) posted Net Margin of -1332200.00% for Q4 2023, down 1321642.54 percentage points from the prior quarter.

Analysis

NovaBridge Biosciences (NBP) Net Margin (2019 - 2023) Analysis & Trends

For FY2023, NovaBridge Biosciences' Net Margin came in at -32664.40%, down 9226.23 percentage points from FY2022.

  • Annual Net Margin has declined for three consecutive years, with a five-year change of -31915.37 percentage points (FY2018 to FY2023).
  • In prior years, NovaBridge Biosciences' Net Margin was -23438.17% in FY2022 (-20789.43 pp), -2648.74% in FY2021 (-2679.26 pp), 30.53% in FY2020 (+4980.82 pp) and -4950.29% in FY2019 (-4201.27 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 21.86%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 21.27%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -8.04%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 22.65%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 16.30%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 23.62%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -134.51%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -1.65%
10 NovaBridge Biosciences 131.20 Mn -664.38 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -1,332,200.00%
Sep 30, 2023 -10,557.46%
Jun 30, 2023 -38,657.86%
Dec 31, 2020 67.96%
Sep 30, 2019 -1,640.29%
API Access

NovaBridge Biosciences Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=NBP&period=max&api_key=YOUR_API_KEY